FBT

First Trust NYSE Arca Biotechnology Index Fund

Up$139.96
+$0.58
(+0.42%)
As of 6:40:00 PM EDT | 6/21/19  |  Market Closed

FBT Trading Data

Open

$139.04

Low Price

$137.83

High Price

$140.11

Previous Last Price

$139.38

Bid Size

$137.58 X 700

Ask Size

$143.05 X 700

FBT Portfolio Data

AUM

$2,907,949,600

Shares

20,850

PE Ratio

19.02

Price / Book Ratio

5.18

Expense Ratio

0.56

Net Asset Value

$139.47

Volume

Volume

45,500

Avg. Volume (YDT)

148,707

Dollar Volume

$0

Weekly Avg. Volume

71,000

Monthly Avg. Volume

93,900

Quarterly Avg. Volume

151,767

FBT Fund Description

The First Trust NYSE Arca Biotechnology Index Fund is and exchange-traded index fund. The investment objective of the fund is to replicate as closely as possible, before fees and expenses, the price and yield of the NYSE Arca Biotechnology Index. The NYSE Arca Biotechnology Index is an equal dollar weighted index designed to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services. Such processes include, but are not limited to, recombinant DNA technology, molecular biology, genetic engineering, monoclonal antibody-based technology, lipid/liposome technology, and genomics. The index is rebalanced quarterly based on closing prices on the third Friday in January, April, July and October to ensure that each component stock continues to represent approximately equal weight in the index.

FBT Chart

FBT Summary

Fund Family

First Trust Portfolios

Tracks This Index

First Trust NYSE Arca Biotechnology Index Fund

Inception Date

2006-06-19

Asset Class

Equity

Asset Class Size

Biotech

FBT Classification

Region (General)

Global

Region (Specific)

Sector

Health Care

Equity Index

Leveraged Family

FBT Holdings

Top 10 Holdings

Exact Sciences Corporation (EXAS)
4.09%
Incyte Corporation (INCY)
3.82%
IQVIA Holdings Inc. (IQV)
3.79%
Bio-Techne Corporation (TECH)
3.7%
Illumina Inc. (ILMN)
3.66%
Nektar Therapeutics (NKTR)
3.65%
Sarepta Therapeutics Inc. (SRPT)
3.64%
ACADIA Pharmaceuticals Inc. (ACAD)
3.56%
Gilead Sciences Inc. (GILD)
3.56%
Neurocrine Biosciences Inc. (NBIX)
3.54%

Total FBT Holdings

Total Holdings: 31

Exact Sciences Corporation (EXAS)
4.09%
Incyte Corporation (INCY)
3.82%
IQVIA Holdings Inc. (IQV)
3.79%
Bio-Techne Corporation (TECH)
3.7%
Illumina Inc. (ILMN)
3.66%
Nektar Therapeutics (NKTR)
3.65%
Sarepta Therapeutics Inc. (SRPT)
3.64%
ACADIA Pharmaceuticals Inc. (ACAD)
3.56%
Gilead Sciences Inc. (GILD)
3.56%
Neurocrine Biosciences Inc. (NBIX)
3.54%
Vertex Pharmaceuticals Incorporated (VRTX)
3.54%
Grifols S.A. (ADR) (GRFS)
3.51%
QIAGEN N.V. (QGEN)
3.51%
Seattle Genetics Inc. (SGEN)
3.41%
Amgen Inc. (AMGN)
3.39%
Biogen Inc. (BIIB)
3.39%
BioMarin Pharmaceutical Inc. (BMRN)
3.39%
Charles River Laboratories International Inc. (CRL)
3.36%
Alexion Pharmaceuticals Inc. (ALXN)
3.34%
Exelixis Inc. (EXEL)
3.3%
Ultragenyx Pharmaceutical Inc. (RARE)
3.22%
Regeneron Pharmaceuticals Inc. (REGN)
3.13%
FibroGen Inc. (FGEN)
3.07%
Intercept Pharmaceuticals Inc. (ICPT)
3.07%
Agios Pharmaceuticals Inc. (AGIO)
2.99%
Alnylam Pharmaceuticals Inc. (ALNY)
2.92%
Ionis Pharmaceuticals Inc. (IONS)
2.9%
bluebird bio Inc. (BLUE)
2.79%
United Therapeutics Corporation (UTHR)
2.54%
Alkermes Plc (ALKS)
2.18%
First Trust NYSE Arca Biotechnology Index Fund (FBT)
0%

FBT Technicals

Alpha

-1.45

Beta

1.5

Leverage

Long

Standard Deviation

9.12

FBT Dividends

Dividend Date

2015-09-23

Latest Dividend

0.02

Annual Dividend

0

Annual Dividend Rate

0

Annual Dividend Yield

1.0E-5

FBT Performance

YTD Return

12.69%

1 Year Return

-3.67%

3 Year Return

61.25%

5 Year Return

70.69%

10 Year Return

561.46%

FBT Related Articles